cabergoline

Note: If treatment with a dopamine agonist is necessary in a person who wishes to breastfeed, and the person is able to produce breastmilk, breastfeeding may be continued with caution. Monitor the infant for adverse effects such as drowsiness, insomnia, dry mouth or constipation.